tm logo
Trademark Search
CENK

View On IC.GC.CA

CENK
APPROVED

on 31 Dec 2024

Last Applicant/ Owned by

IMMUNITYBIO, INC.

3530 John Hopkins CourtSan Diego CA 92121

US

Serial Number

2087269 filed on 04th Jan 2021

Correspondent Address

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

CENK

Trademark usage description

cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations for scien Read More

Classification Information

Class [001]
Cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations for scientific, laboratory, medical, clinical laboratory, therapeutic, and diagnostic research in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations, reagents and related instructions, for clinical laboratory, medicinal, and therapeutic research purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes.

Classification kind code

11

Class [005]
Cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; therapeutic products derived from cells and cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations, for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; kits comprised of cells, namely, human-derived lymphocytes and natural killer cells, reagents and related instructions, for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid; kits comprised of cell-derived preparations, namely, human-derived lymphocytes and natural killer cells and natural killer cell-derived preparations, reagents and related instructions, for clinical laboratory, medical, veterinary, and therapeutic purposes in the fields of the treatment of cancer and inflammatory and infectious diseases, and for antibody and biologic product testing and assessment in the fields of the aforesaid.

Classification kind code

11

Class [044]
Providing information relating to clinical, medicinal, and therapeutic properties of cells and cell-derived preparations.

Classification kind code

11

Mark Details

Serial Number

2087269

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 21st Jun 2022		Search Recorded
Submitted for opposition 20
on 21st Jun 2022		Examiner's First Report
Submitted for opposition 256
on 27th Dec 2021		Notification of Possible Opposition Sent
Submitted for opposition 135
on 19th Aug 2021		Amendment to Application
Submitted for opposition 48
on 21st Apr 2021		Agent Changed
Submitted for opposition 257
on 25th Feb 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 24th Feb 2021		Created
Submitted for opposition 31
on 24th Feb 2021		Formalized
Submitted for opposition 30
on 04th Jan 2021		Filed
Submitted for opposition 228
on 04th Jan 2021		International Registration